Sponsor pipeline

University College, London clinical trial pipeline

Get alerts when University College, London's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

What changed in the last 30 days

4 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 4 with minor changes only.

  1. Minor
    3 trials marked Unknown by the registry's verification sweep

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-21 NCT07831902 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO)… Phase 3 Recruiting

Active trials by phase

Early Phase 1
1
Phase 1
12
Phase 1/2
5
Phase 2
19
Phase 2/3
2
Phase 3
19
Not charted: 99 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 157

NCT IDTitleConditionStatusUpdated
Phase 3
NCT07831902 Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO)… Endometrial Cancer Recruiting 2026-09-21
NCT07751133 Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer Prostate Cancer Recruiting 2026-09-04
NCT07724132 An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic… Alzheimer's Disease (AD) Recruiting 2026-07-23
NCT04685616 Brentuximab Vedotin in Early Stage Hodgkin Lymphoma Hodgkin Lymphoma Recruiting 2026-07-08
NCT07207057 Edmond J. Safra Accelerating Clinical Trials in Parkinson's Disease: A Multiarm… Parkinsons Disease (PD) Recruiting 2025-10-03
NCT06320067 A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive… Prostate Cancer Metastatic Recruiting 2025-09-26
NCT05778617 Ambroxol to Slow Progression in Parkinson Disease Parkinson Disease Recruiting 2025-05-01
NCT05405868 Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase… Glaucoma, Open-Angle Recruiting 2024-05-09
NCT03288532 Renal Adjuvant MultiPle Arm Randomised Trial Renal Cell Carcinoma Recruiting 2020-09-07
NCT07813351 PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy… Acromegaly Due to Pituitary Adenoma Not Yet Recruiting 2026-10-01
NCT07792096 An Adaptive Platform Trial for Evaluation of Novel Treatment Regimens in Children and… HIV Infection Not Yet Recruiting 2026-08-28
NCT07726693 Apixaban to Prevent Decompensation of Early Liver Cirrhosis Trial Liver Cirrhosis Not Yet Recruiting 2026-07-24
NCT07163143 Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed… Tuberculosis (TB) Not Yet Recruiting 2025-09-09
NCT02804815 Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival… Cancer Active, Not Recruiting 2025-06-10
NCT05073835 Semaglutide 2.4 mg in Patients With Poor Weight-loss Obesity Active, Not Recruiting 2024-12-06
NCT01566240 Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced… Cervical Cancer Active, Not Recruiting 2024-12-05
NCT06242782 Vertical Ridge Augmentation Strategies Alveolar Bone Resorption Not Yet Recruiting 2024-02-05
NCT00943423 PET Scan in Planning Treatment in Patients Undergoing Combination Chemotherapy For Stage… Lymphoma Active, Not Recruiting 2023-11-30
NCT02544308 Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Plasmacytoma Active, Not Recruiting 2022-12-23
Phase 2/3
NCT04061512 Rituximab and Ibrutinib (RI) Versus Dexamethasone, Rituximab and Cyclophosphamide (DRC)… Waldenstrom Macroglobulinemia Recruiting 2024-05-10
NCT01398085 IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer… Thyroid Cancer Active, Not Recruiting 2026-05-07
Phase 2
NCT06114628 Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB Pulmonary Tuberculosis Recruiting 2026-10-15
NCT07202949 A Clinical Trial of Extended (High) Treatment Dose Antibiotics in Combination With… Chronic Urinary Tract Infection Recruiting 2026-10-14
NCT06762769 Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma Smouldering Myeloma Recruiting 2025-08-01
NCT05635162 Zanubrutinib Plus Rituximab for Patients With Indolent Mantle Cell Lymphoma Mantle Cell Lymphoma Recruiting 2025-04-16

Disease areas by active trials, top 10 of 46

Get alerts when University College, London's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free